29th Annual Drug & Medical Device Litigation Conference
Event | 12.03.24, 8:30 AM EST - 9:30 AM EST | CLE Offered
Address
New York Marriott Marquis
1535 Broadway, New York, NY 10036
Andrew Kaplan will speak on the panel "Drug and Medical Device Litigation Year in Review" which will explore these critical changes, dissecting their real-world impacts and forecasting their influence on future litigation trends and strategies. Topics of discussion will include:
- Surveying the year’s most significant and influential court decisions involving drug and medical device claims
- Analyzing pending decisions that may have the most foreseeable future impact
- Updating practice and litigation strategies in response to the latest case law development
- Coordinating within the defense bar to “level the playing field”
For more information, please visit these areas: Mass Tort, Product, and Consumer Litigation, Class Action Defense, Litigation and Trial, Product Liability Class Actions, Medical Devices, Product Risk Management, National Coordinating Counsel and Complex Litigation, Life Sciences
Participants
Insights
Event | 12.04.25
ACI 30th Annual Conference on Drug & Medical Device Litigation
Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.
Event | 12.03.25 - 12.04.25
Caroline Brown to Speak at ACI New York Forum on Economic Sanctions
Event | 11.04.25
